PAR 0.00% 34.5¢ paradigm biopharmaceuticals limited..

News: PAR Paradigm Biopharmaceuticals completes Phase 2A clinical trial in bone marrow lesions

  1. 184,653 Posts.
    lightbulb Created with Sketch. 2711

    Nov 14 (Reuters) - Paradigm Biopharmaceuticals Ltd (PAR)

    • Successfully completes Phase 2A clinical trial in bone marrow lesions
    • Phase 2A clinical trial in bone marrow lesions (bone bruising) met its primary endpoint of safety & tolerability
    • Secondary endpoint was met and showed a statistically significant reduction in bone marrow lesion volume
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
34.5¢
Change
0.000(0.00%)
Mkt cap ! $120.9M
Open High Low Value Volume
35.5¢ 36.0¢ 34.5¢ $101.9K 292.7K

Buyers (Bids)

No. Vol. Price($)
4 39147 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 21134 2
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
35.0¢
  Change
0.000 ( 1.92 %)
Open High Low Volume
35.0¢ 36.0¢ 34.5¢ 115057
Last updated 15.59pm 29/03/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.